Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Capital Raises) (Narrative) (Details)

v3.23.1
Stockholders' Equity (Capital Raises) (Narrative) (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Dec. 30, 2022
USD ($)
Dec. 27, 2022
USD ($)
$ / shares
shares
Dec. 16, 2022
USD ($)
Oct. 11, 2022
USD ($)
item
$ / shares
shares
Mar. 04, 2022
USD ($)
Nov. 16, 2021
USD ($)
$ / shares
shares
Oct. 23, 2020
USD ($)
Feb. 28, 2023
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Nov. 30, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
Nov. 30, 2020
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Oct. 31, 2022
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common Stock, par value | $ / shares                 $ 0.001 $ 0.001       $ 0.001 $ 0.001   $ 0.001
Proceeds from Issuance of Common Stock                           $ 6,053 $ 9,085    
Loss on common stock warrant liabilities                           (1,129) 447    
Proceeds from debt                           $ 47,112 $ 0    
Common Stock [Member] | MLV & Co. and FBR Capital Markets & Co [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, price per share | $ / shares                 3.05         $ 3.05      
Series A Perpetual Preferred Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Preferred Stock, dividend rate percentage                           9.375%      
Journey | Convertible ClassA Preferred Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                           758,680 81,985    
Stock offering, price per share | $ / shares                 25.00 10.00       $ 25.00 $ 10.00    
Stock offering, gross proceeds                           $ 19,000      
Stock offering, aggregate fees paid                           1,900      
Sale of stock, net proceeds                           17,000      
Preferred Stock, dividend rate percentage                       8.00%          
Stock offering other fees paid                           $ 100      
Journey | Convertible ClassA Preferred Stock [Member] | Preferred Stock has not been Converted into Journey Common Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Preferred stock offering, aggregate proceeds                       $ 25,000          
Checkpoint | Common Stock and Pre-funded Warrants                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Net proceeds     $ 0                            
Avenue Therapeutics, Inc [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Shares issued | shares       3,636,365                          
Warrants issued | shares       545,454                          
Number of shares called by warrants | shares       1                          
Number of warrants to purchase shares | shares       545,454                          
Number of common stock (in units) | item       1                          
Number of warrants (in units) | item       1                          
Proceeds from Issuance of Common Stock       $ 10,300                          
Avenue Therapeutics, Inc [Member] | InvaGen [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Percentage of shares repurchased       100.00%                          
Purchase price of shares repurchased       $ 3,000                          
Avenue Therapeutics, Inc [Member] | InvaGen [Member] | Share repurchase agreement                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Percentage of shares repurchased       100.00%                          
Purchase price of shares repurchased       $ 3,000                          
Avenue Therapeutics, Inc [Member] | Pre-Funded Warrants [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of shares called by warrants | shares       1                          
Exercise price of warrants | $ / shares       $ 0.0001                          
Unit Price Per Share | $ / shares       $ 3.2999                          
Number of warrants (in units) | item       1                          
Avenue Therapeutics, Inc [Member] | Common Stock and Pre-funded Warrants                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Unit Price Per Share | $ / shares       $ 3.30                          
Number of warrants (in units) | item       1                          
Urica | Convertible Class B Preferred Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares   101,334                              
Stock offering, price per share | $ / shares   $ 25.00                              
Stock offering, gross proceeds   $ 2,500           $ 900                  
Stock offering, aggregate fees paid   300           100                  
Sale of stock, net proceeds   $ 2,200           $ 800                  
Preferred Stock, dividend rate percentage   8.00%                              
Maximum | Journey | Convertible ClassA Preferred Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Preferred stock offering, aggregate proceeds                       30,000          
Minimum | Journey | Convertible ClassA Preferred Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Preferred stock offering, aggregate proceeds                       $ 12,500          
Runway Note [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Proceeds from debt         $ 30,000                        
Debt instrument face amount         75,000                        
Runway Note [Member] | Financial Milestones [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Debt instrument face amount         $ 45,000                        
At the Market Offering [Member] | Common Stock [Member] | Cantor Fitzgerald & Co., Oppenheimer & Co., Inc., H.C. Wainwright & Co. Inc., Jones Trading Institutional Services LLC. B. Riley and Dawson James Securities, Inc [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                           4,100,000 3,100,000    
Stock offering, price per share | $ / shares                 $ 1.50 3.05       $ 1.50 $ 3.05    
Stock offering, gross proceeds                           $ 6,200 $ 9,400    
Stock offering, aggregate fees paid                           $ 200 $ 300    
At the Market Offering [Member] | Journey                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of shares available for future issuance | shares                 4,900,000         4,900,000      
Common Stock, par value | $ / shares                 $ 0.0001         $ 0.0001      
At the Market Offering [Member] | Checkpoint | Common Stock [Member] | Founders Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                             56,671 29,749  
Shares issued (in percent)                           2.50%      
At the Market Offering [Member] | Mustang | Common Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                             19.4 7,900,000  
Stock offering, price per share | $ / shares                   $ 3.70         $ 3.70 $ 0.84  
Stock offering, gross proceeds                             $ 71,900 $ 6,600  
Stock offering, aggregate fees paid                             1,300 100  
Sale of stock, net proceeds                             $ 70,600 $ 6,500  
At the Market Offering [Member] | Mustang | Common Stock [Member] | Founders Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                             196,952 576,157  
Shares issued (in percent)                             2.50%    
Public Offering [Member] | Avenue Therapeutics, Inc [Member] | Common Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                   1,910,100 2,238,805            
Stock offering, price per share | $ / shares                   $ 1.07 $ 1.34       $ 1.07    
Stock offering, gross proceeds                   $ 2,000 $ 3,000            
Sale of stock, net proceeds                   $ 1,800 $ 2,600            
Shelf Registration Statement [Member] | Common Stock [Member] | Cantor Fitzgerald & Co., Oppenheimer & Co., Inc., H.C. Wainwright & Co. Inc., Jones Trading Institutional Services LLC. B. Riley and Dawson James Securities, Inc [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Amount available for future stock offerings                 $ 11,100         $ 11,100      
Shelf Registration Statement [Member] | Journey                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, aggregate offering permitted by the agreement $ 150,000                                
Amount available for future stock offerings                 $ 150,000         $ 150,000      
Shelf Registration Statement [Member] | Checkpoint                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, commission rate                         3.00%        
Shelf Registration Statement [Member] | Checkpoint | Common Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares                           532,816 1,189,999    
Stock offering, price per share | $ / shares                 $ 18.99 $ 34.69       $ 18.99 $ 34.69    
Stock offering, gross proceeds                           $ 10,100 $ 41,300    
Sale of stock, net proceeds                           9,900 40,300    
Amount available for future stock offerings                   $ 22,300         22,300    
Shelf Registration Statement [Member] | Mustang                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, aggregate offering permitted by the agreement                             $ 200,000    
Amount available for future stock offerings                 $ 200,000         200,000      
Shelf Registration Statement [Member] | Maximum | Checkpoint                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, aggregate offering permitted by the agreement                         $ 100,000        
Mustang 2020 S-3 [Member] | Mustang                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, aggregate offering permitted by the agreement             $ 100,000                    
Amount available for future stock offerings                 8,000         $ 8,000      
IPO [Member] | Journey                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock offering, number of shares issued | shares           3,520,000                      
Stock offering, price per share | $ / shares           $ 10.00                      
Stock offering, aggregate fees paid           $ 4,600                      
Sale of stock, net proceeds           $ 30,600                      
Direct Offering [Member] | Checkpoint                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Sale of stock, net proceeds                 6,700                
Loss on common stock warrant liabilities                 (1,200)                
Net proceeds                 $ 0                
Direct Offering [Member] | Checkpoint | Common Stock Warrants [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Shares issued | shares                 950,000                
Unit Price Per Share | $ / shares                 $ 4.325         $ 4.325      
Direct Offering [Member] | Checkpoint | Pre-Funded Warrants [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Warrants issued | shares                 784,105                
Number of shares called by warrants | shares                 1         1      
Per share price of warrants | $ / shares                 $ 0.0001         $ 0.0001      
Unit Price Per Share | $ / shares                 $ 4.33249         $ 4.33249      
Direct Offering [Member] | Checkpoint | Series A Warrants [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of warrants to purchase shares | shares                 1,734,105         1,734,105      
Exercise price of warrants | $ / shares                 $ 4.075         $ 4.075      
Warrant expiration term                 5 years         5 years      
Direct Offering [Member] | Checkpoint | Series B Warrants [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of warrants to purchase shares | shares                 1,734,105         1,734,105      
Exercise price of warrants | $ / shares                 $ 4.075         $ 4.075      
Warrant expiration term                 18 months         18 months